Taiwan Pharmaceuticals & Healthcare Q1 2020

Key View:

While innovation is recognized in Taiwan, novel pharmaceutical products will continue to see constraints to their growthprospects. The government will continue to strictly regulate spending on patented medicines to ensure the financial sustainabilityof Taiwan’s universal healthcare program, given the rising costs associated with meeting its rapidly ageing population medicalneeds. Nonetheless, the Taiwanese pharmaceutical market will continue to be highly attractive for multinational drugmakers,reinforced by its high pharmaceutical spending per capita and advanced healthcare infrastructure.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Asia Pacific Innovative Pharmaceuticals Risk/Reward Index
Taiwan Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Sanofi
GlaxoSmithKline
Merck & Co
Novartis
Pfizer
ScinoPharm Taiwan
TaiGen
Yung Shin Pharmaceutical
Taiwan Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook